{"id":61291,"date":"2024-11-04T12:05:32","date_gmt":"2024-11-04T12:05:32","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/11\/04\/arvinas-to-participate-in-upcoming-investor-conferences\/"},"modified":"2024-11-04T12:05:32","modified_gmt":"2024-11-04T12:05:32","slug":"arvinas-to-participate-in-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/","title":{"rendered":"Arvinas to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div>\n<p align=\"left\">NEW HAVEN, Conn., Nov.  04, 2024  (GLOBE NEWSWIRE) &#8212; Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will participate in two upcoming investor conferences:<\/p>\n<ul type=\"disc\">\n<li><strong>Guggenheim Securities Healthcare Innovation Conference <\/strong>on Wednesday, November 13.\n<ul type=\"circle\">\n<li>Noah Berkowitz, MD, Ph.D. Chief Medical Officer, and Randy Teel, Ph.D., Chief Business Officer, will participate in a fireside chat. A live audio webcast of the presentation will be available <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=M7_bOTo88OViUA3CUQd9LJR6raB-xnz-zxMyUauvhcBfNExLD_mtXd1hRC4WVddm19HUm89QO6sFKbJdj3eCJ0glTIEi9w3j4lSrL1So-PI7WsdU8gop8qMCKATQu5-FSyvbJ0MP8RQF-Q0m7cVSrjsvKQdEuQ0UFPBZtri4ChJI9MfekQiiB7Qhwp8iOV6g7zoBdr6Xyvg7Zp8pN1fxL72PvsK6XfyZRZ17oOFf8mlZVhgeny0QszG5XvYML-60SRPjopHmH4a9_VVtVS1n8ZWaTL8Ty6PRh13L_UyllJK02H4Bxom8akROv2vnq2KwFZRWvM2fssEZaecaiOCihQkVl6OTGe5785NKtYBgnFnljGAxI5ILNWRCu4-HeXRKeAL5e6mMfHRzVhT4-d-_QSwuDY-T88RxAGwnJv3SgENfqplIn1AXKEbmIHGbR7Z1NnNfmaHzi1pNMYAJqNdLwkPExanOUkA_59xJ-jfinR6gu54SI1j6ZTdxs0lzISPBGJ_rdzQTGppph_pTuBoj-tQb8WnzqCOhOiDcJgPb_V9kSmNe8qMggIvO1MAOJhIiIa2hkv-8ELkKjFz3LY6p9fS8o5DRGT67D9cqGZFPfu0=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"here\">here<\/a> and on the Events and Presentations section of the Company\u2019s website.<\/li>\n<\/ul>\n<\/li>\n<li><strong>Jefferies London Healthcare Conference <\/strong>on Tuesday, November 19.\n<ul type=\"circle\">\n<li>Noah Berkowitz, MD, Ph.D. Chief Medical Officer, and Andrew Saik, Chief Financial Officer, will participate in a fireside chat. A live audio webcast of the presentation will be available <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=M7_bOTo88OViUA3CUQd9LLxmHDV5yfGdTRhQ6siFTNSgcirn7HDgkRH9n-C8qPtnGH34LBskApbTzDufU6ptBpgdNAu41Wf-A1rb8J9vL6U=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"here\">here<\/a> and on the Events and Presentations section of the Company\u2019s website.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>About Arvinas<\/strong><br \/>Arvinas (Nasdaq: ARVN) is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. Through its PROTAC\u202f(PROteolysis Targeting Chimera) protein degrader platform, the Company is pioneering the development of protein degradation therapies designed to harness the body\u2019s natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+\/HER2- breast cancer; ARV-393, targeting BCL6 for relapsed\/refractory non-Hodgkin Lymphoma; and ARV-102, targeting LRRK2 for neurodegenerative disorders. Arvinas is headquartered in New Haven, Connecticut. For more information about Arvinas, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qO_4KiTH_BaW2GcYl_YbT_MDO64ff8EZdsBAo3bglXVt62v8kZMDtAtzdSJ1SWMgr73INi--yE0wMvmGgbE6Ow==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.arvinas.com\">www.arvinas.com<\/a> and connect on\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zFmqrTIvsSSIJUKog_kRVkey8hDMlbn9BZp-otW188_nu4XiuA9Wuge5FNcVvdMmVNSqpnJt6OO_yWbgBxu0UK-PNcXkWSNXn3AcfayuDRy4xiFZBzrEo3u-BLwO5Yxg2WVHnIUIWlYHwXF44AIAwfWKfVm6m4qYpx5q6k7gmhd4IUwO99aahdy983U_eKu0_0dqgAxMKA1Cs_Wmm7Boc1zp9i0nxc-JYKrPQVsiIC9zNvNeqTGhZJF3Zk6dYqDSo7rpcyCrTxlEvF-9KuZqGIgIj1rBDlx_7KUeGY__c75ABNReR_Vr9tIzHYm8sSbLtvWWJnUhpOUij5cXfl59TD7WhE9QIATGt_7xHRLumt5_eyP6oOF7skjW5eXht1iQllgqaM-3N9ZFZbh4-wqT-Wlxhhes0-PSksTi3hsIbNR66lQlUj9h6eSzpWuhxS5d\" rel=\"nofollow noopener\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hHzN8DD8CSVpXC_UM1A0Nhn_zaOV7uJzHYJZW9yRJozcYXBQpn02rv5w9myq7TtZ34aCWIKYfHTL4JXFzUCghgYXvQz3aRNYTwM1S7-9SKfazLCf-cqXPr_JlghQM8md4xN3mIDUcQh2XhalcdEwBcMuarWhfJnB2BWuJ6IzmokFVGH3qkHgEJV-AcmUxKEavOjPQdJF7GhenRHgC1Jp1IsYTnVdGKYREnfi8hcj9aYrmLC8UKP-aXu4fK0jS3B1uzEiOF-XsFYZGyl4ZiRt_-qsX-4EFM_ZfqBm8dYrmML_ayFCMzH4ZPyRPE7wOwvpugr-7bO8Qfd1xTZGxbuNff98LJNZTHP50am8RU2ehLlDtUjADhl7SU1EYHrVdvy5\" rel=\"nofollow noopener\" target=\"_blank\" title=\"X\">X<\/a>.<\/p>\n<p><strong>Contacts <\/strong><\/p>\n<p><strong>Investors:<\/strong><br \/>Jeff Boyle<br \/>+1 (347) 247-5089<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VZJBKdq5uTgW1lLOILkt2bDAoKBYsWo95AJtt24mOIfHk_rM2Jo7dVwu2jx6yz5SQchYKDO-a264flFqBr-hPVmlNapx7U88b6fAKKK1ZuWA6Zn1fmOR7PXzjodkRAXLzzI0VbA4osnNKJnr1rhDMhkJGUvnX05Xfq-NwR3T2jljdrGYUA2k0N7c89gShaZO31gJYPXXbyWqmST4U7-YqSv-ZwSbD7XPf0BoVXWqUWoSJ3JoVHbJ35AXazcqcYRO8BTgFx5vZb73QNBTQhhzuw==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Jeff.Boyle@arvinas.com\">Jeff.Boyle@arvinas.com<\/a><\/p>\n<p><strong>Media:<\/strong><br \/>Kirsten Owens<br \/>+1 (203) 584-0307<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-wBnigcvLfG5nq6OmTW75d4rJdTcY80nAdfLFCESmgY7at6EFKz9IbHWhTqkmg_rAgQxu8sUgHUoYqgqb_jOvTcK3AvDR8S2p2dhhV-aZYh6YcTPeCrPeQ1VF1PsyT7QnhpPJti4U3OrhJMndFmuwPOXByRMyNwd_aAmFY1HotbPALIAkEuQwLjL5jxC6jJL_ZBQdiks3Ca7pPFfjOzH6K9L_iZEOBCYvmwQklrzbkmU3WFNFS3Bkn4uA0W-Ey9yRFkYToYUf4aEysqy2yxzHySa2SY-Nn-Fz3rPmxqqdFsAVXqijhFupeiG9DDzlpWDPWsRUjE1XIaKwxA03UZg8HTLYM4CvVjwuLO67XGXnloIfvXSIrEkZCZVL2kdeYyhMYgZ3unat6gnRdSvaR79gYUTvxyH69wvVk6gnK9Sq2y7quUY5pDG-PoDzsFzFyLfBrdH140trNjLxWScdTAcX0RVmx6wFx78qY-ha_KPTUK9eF_o8QdHt31YlYa2GCR8\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Kirsten.Owens@arvinas.com\">Kirsten.Owens@arvinas.com<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/N2M1NGFlNzAtNjA2ZS00MWM0LTliYTctMzY0Njg1MzM2MWI5LTExMzM2NDc=\/tiny\/Arvinas-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW HAVEN, Conn., Nov. 04, 2024 (GLOBE NEWSWIRE) &#8212; Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will participate in two upcoming investor conferences: Guggenheim Securities Healthcare Innovation Conference on Wednesday, November 13. Noah Berkowitz, MD, Ph.D. Chief Medical Officer, [&#8230;]\n","protected":false},"author":1,"featured_media":61292,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-61291","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Arvinas to Participate in Upcoming Investor Conferences - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arvinas to Participate in Upcoming Investor Conferences\" \/>\n<meta property=\"og:description\" content=\"NEW HAVEN, Conn., Nov. 04, 2024 (GLOBE NEWSWIRE) &#8212; Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-04T12:05:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/11\/Arvinas-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Arvinas to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2024-11-04T12:05:32+00:00\",\"dateModified\":\"2024-11-04T12:05:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/\"},\"wordCount\":291,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/\",\"name\":\"Arvinas to Participate in Upcoming Investor Conferences - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-11-04T12:05:32+00:00\",\"dateModified\":\"2024-11-04T12:05:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arvinas to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Arvinas to Participate in Upcoming Investor Conferences - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Arvinas to Participate in Upcoming Investor Conferences","og_description":"NEW HAVEN, Conn., Nov. 04, 2024 (GLOBE NEWSWIRE) &#8212; Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of","og_url":"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-11-04T12:05:32+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/11\/Arvinas-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Arvinas to Participate in Upcoming Investor Conferences","datePublished":"2024-11-04T12:05:32+00:00","dateModified":"2024-11-04T12:05:32+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/"},"wordCount":291,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/","url":"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/","name":"Arvinas to Participate in Upcoming Investor Conferences - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-11-04T12:05:32+00:00","dateModified":"2024-11-04T12:05:32+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/arvinas-to-participate-in-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Arvinas to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/61291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=61291"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/61291\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/61292"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=61291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=61291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=61291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}